Human papillomavirus type bivalent virus-like particle mixed protein antigen and construction method
A technology of human papillomavirus and protein antigen, applied in antiviral agents, pharmaceutical formulations, animal/human peptides, etc., can solve the problems of high recurrence rate of condyloma acuminatum and lack of treatment methods
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0005] Embodiment 1: The bivalent virus-like particle mixed protein antigen of this embodiment includes a L1 antigen of a cervical cancer-causing virus HPV16 and a L1 antigen of a condyloma acuminatum virus HPV11.
specific Embodiment approach 2
[0006] Embodiment 2: This embodiment is different from Embodiment 1 in that it also includes a vector, which is a Bacmid plasmid.
specific Embodiment approach 3
[0007] Specific embodiment three: In this embodiment, the bivalent virus-like particle mixed protein antigen is constructed according to the following method: the HPV11L1 gene is cloned from condyloma acuminata tissue by molecular biology methods, and the HPV16L1 gene and HPV11L1 gene are double-expressed in baculovirus insect cells Expression system to construct recombinant virus strain Bacmid / HPV16-HPV11L1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com